CIMZIA® label change marks an important advance for women in the UK of childbearing age with moderate to severe active rheumatoid arthritisRA news | 15 Jan 2018
The European Medicines Agency (EMA) has approved the label change for UCB’s CIMZIA® (certolizumab pegol), making it the first anti-TNF for potential use in women with moderate to severe active rheumatoid arthritis, active psoriatic arthritis and ankylosing spondylitis during both pregnancy and breastfeeding.
NRAS News | 14 Dec 2017
NRAS will be closed for the Christmas holidays from 1pm on Friday 22nd December and will reopen on Tuesday 2nd January.
NRAS News | 13 Nov 2017
UK charity for rheumatoid arthritis and juvenile idiopathic arthritis, NRAS, partners with Danish health company for launch of RheumaBuddy.
NRAS News | 2 Nov 2017
NRAS embarked on a joint collaboration with the Oxford Academic Health Science Network (OAHSN) supported by Sandoz Pharmaceuticals to raise public awareness of RA.
RA news | 24 Oct 2017
NRAS has been notified of a problem with the throttle on some of the TGA S range of scooters.
NRAS News | 11 Oct 2017
Today, NRAS announces findings from a study conducted in partnership with the University of Manchester that investigates the impact of Rheumatoid Arthritis (RA) and adult Juvenile Idiopathic Arthritis (JIA) in the workplace.
RA news | 10 Oct 2017
NRAS recently had an enquiry about the “nasal” spray flu vaccine that is being rolled out in schools to children which prompted us ask some of our medical advisors for some guidance.
RA news | 20 Sep 2017
Treated.com held an interview with NRAS' CEO, Ailsa, to discuss what people should know about rheumatoid arthritis.
NRAS News | 14 Sep 2017
The Disability Benefits Consortium (DBC) today released a report 'Supporting those who need it most?' following a survey of 1700 people with long-term conditions, including rheumatoid arthritis.
NRAS News | 16 Aug 2017
Last week, the NHS announced plans to stop certain prescriptions that are considered to be either ineffective or low cost enough that patients can buy themselves.